Document Download Tool

Personalized Document Selection & Download

Debt Investor Information 2021-02-25
FY/Q4 2020 All in One Download Package
FY/Q4 2020 Investor Conference Call Presentation Charts
Transcript FY Q4 2020 Investor Conference Call 2021-02-25
Financial Key Figures 2020 as Excel files
Corporate Governance Declaration of Conformity 2020
Morgan Stanley Global Chemicals and Ag Conference 2020-11-10
Debt Investor Information 2020-11-03
Q3 2020 All in One Download Package
Q3 2020 Investor Conference Call Presentation Charts
Quarterly Statement Third Quarter 2020
Transcript Q3 2020 Investor Conference Call 2020-11-03
Debt Investor Information 2020-10-05
Bayer AG Ad-hoc Announcement September 30, 2020
Transcript Investor Conference Call 2020-09-30, Bayer to accelerate transformation
Bayer ESG Update Presentation 2020-09-17
Credit Suisse Basic Materials Conference September 17, 2020
Transcript ESG Investor Conference Call 2020-09-17
Bonds Outstanding at Bayer as of August 2020
Q2 2020 All in One Download Package
Q2 2020 Investor Conference Call Presentation Charts
Transcript Q2 2020 Investor Conference Call 2020-08-04
Transcript Investor Conference Call 2020-06-25, Q&A
Bayer AG Ad-hoc Announcement June 24, 2020
Investor Conference Call Script June 24 2020
Transcript Investor Conference Call 2020-06-24, Q&A
Deutsche Bank Virtual Access Berlin Conference June 4, 2020
UBS Global Healthcare Virtual Conference May 19, 2020
Berenberg Virtual USA Conference 2020 May 18, 2020
BMO Global Farm to Market Virtual Conference May 14, 2020
Quarterly Statement First Quarter 2020
Q1 2020 All in One Download Package
Q1 2020 Investor Conference Call Presentation Charts
Transcript Q1 2020 Investor Conference Call 2020-04-27
BoAML Global Agriculture+Materials Conference February 27, 2020
Crop Science R&D Pipeline Update Presentation 2020-02-13
Transcript Crop Science R&D Pipeline Update Call 2020-02-13
J.P. Morgan Healthcare Conference January 14, 2020
Commerzbank German Investment Seminar January 13, 2020
FY/Q4 2018 All in One Download Package
FY/Q4 2018 Investor Conference Call Presentation Charts
Q4 2018 Analyst and Investor Briefing
Transcript FY/Q4 2018 Investor Conference Call 2019-02-27
Capital Markets Day London 2018-12-05 Investor Handout
Capital Markets Day London 2018-12-05 Investor Handout - BayerGroup
Capital Markets Day London 2018-12-05 Investor Handout - Financials
Capital Markets Day London 2018-12-05 Investor Handout - Pharmaceuticals
Capital Markets Day London 2018-12-05 Investor Handout – Ag Introduction
Capital Markets Day London 2018-12-05 Investor Handout – Consumer Health
Capital Markets Day London 2018-12-05 Investor Handout – Crop Science
Capital Markets Day London 2018-12-05 Investor Handout – CS Commercial Execution
Capital Markets Day London 2018-12-05 Investor Handout – CS Digital Transformation
Capital Markets Day London 2018-12-05 Investor Handout – CS Innovation
Transcript CMD 2018-12-05 Crop Science Advancing the Digital Transformation
Transcript CMD 2018-12-05 Crop Science Excellence in Commercial Integration and Execution
Transcript CMD 2018-12-05 Crop Science Introduction to Agriculture
Transcript CMD 2018-12-05 Crop Science World Class Innovation Platform
Transcript CMD 2018-12-05 Morning Presentations and Q&A
Bayer AG Ad-hoc Announcement November 29, 2018
Q3 2018 All in One Download Package
Q3 2018 Analyst and Investor Briefing
Q3 2018 Investor Conference Call Presentation Charts
Transcript Q3 2018 Investor Conference Call 2018-11-13
Supplemental information ahead of Q3 2018 results
Q2 2018 All in One Download Package
Q2 2018 Analyst and Investor Briefing
Transcript Q2 2018 Investor Conference Call 2018-09-05
Transcript Investor Conference Call 2018-08-23, Discussion Glyphosate Litigation
Supplemental financial information ahead of Q2 2018 results
Bayer AG Capital Increase Prospectus June 5, 2018
Bayer AG Subscription Offer June 5, 2018
Bayer AG Ad-hoc Announcement June 03, 2018
Monsanto Acquisition Update June 2018
ASM 2018 Countermotions and election proposals
ASM 2018 Report of the Board of Management regarding the utilization of the Authorized Capital II
ASM 2018 Update of the proposed resolution regarding Item 1